PubMed Health⌕ Search

Biomedical subjects

R Merad

Publications and source records attributed to R Merad.

7 recordsLinked to original sources
PubMed1992

[Evaluation of 1st semester activity of the Algiers Poison Center].

The Poisons Center located in Bab el Oued University Hospital of Algiers has been opened to the public since January 2, 1991. The staff is made of public health physicians and pharmacists residents trained in toxicology. Phone calls are a new means for obtaining advice on poisonings and the public must be informed on the modalities of use. The number of calls shows that people are willing to use this fast and effective medium. A specific data sheet was created. The analysis of calls includes the origin of call, the nature of products used, the age range the clinical condition of patients, the recommended treatment and the outcome when known.

Adolescent↗
PubMed1980

[Oral administration effects, with different doses, of arginine aspartate and arginine chlorhydrate upon growth hormone and free fatty acids plasmatic rates in normal fasting children (author's transl)].

With an equivalent arginine base furniture, arginine chlorhydrate (CA) and arginine aspartate (AA) are orally administered, with variable doses, to normal fasting children, to study during 4 hours evolution of plasmatic growth hormone rates (stimulation of endogenous GH secretion) and plasmatic free fatty acids rates (secondary effects on effectors). With CA 5 g (half dose) opr 10 g (total dose, about 500 mg/kg) mean plasmatic GH rates increase is etale and non significant, when compared to normals. With AA 7,35 g (half dose) or 14,70 g (total dose), there is a 2 h GH peak, when compared to initial values and 2 h normal values (p less than 0,05 or p less than 0.01). Area increases with the two doses AA, when compared to normals (p less than 0,01). With the two products, mean 1 h plasmatic FFA rate does not vary or non significantly decreases. 4 h rate increases, when compared to normals, with CA and AA half dose (p less than 0,05) and CA and AA total dose (p less than 0,01).

Administration, Oral↗